Back
Day Range
$29.28
$30.42
52-Week Range
$12.47
$37.35
Volume
8,167,584
50D / 200D Avg
$32.63
/
$23.84
Prev Close
$29.14
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 24.3 | 0.2 |
| P/B | 4.3 | 3.0 |
| ROE % | 21.2 | 3.6 |
| Net Margin % | 8.2 | 3.8 |
| Rev Growth 5Y % | 2.1 | 9.9 |
| D/E | 2.2 | 0.2 |
Analyst Price Target
Hold
$38.33
+30.1%
Low: $35.00
High: $41.00
Forward P/E
10.89
Forward EPS
$2.70
EPS Growth (est.)
+0.0%
Est. Revenue
16.66B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$4.06
$4.01 – $4.12
|
19.10B | 1 |
| FY2029 |
$3.58
$3.54 – $3.64
|
18.25B | 1 |
| FY2028 |
$3.44
$2.25 – $4.45
|
17.90B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-28 | $0.64 | $0.96 | +49.8% |
| 2025-11-05 | $0.68 | $0.78 | +14.7% |
| 2025-07-30 | $0.63 | $0.66 | +4.8% |
| 2025-05-07 | $0.47 | $0.52 | +10.6% |
| 2025-01-29 | $0.69 | $0.71 | +2.9% |
| 2024-11-06 | $0.65 | $0.69 | +6.2% |
| 2024-07-31 | $0.57 | $0.61 | +7.0% |
| 2024-05-08 | $0.51 | $0.48 | -5.9% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Nov 27, 2017 | Dec 12, 2017 | $0.09 | 5.80% |
| Aug 25, 2017 | Sep 14, 2017 | $0.09 | 6.82% |
| Jun 01, 2017 | Jun 22, 2017 | $0.34 | 4.69% |
| Feb 28, 2017 | Mar 20, 2017 | $0.34 | 3.88% |
| Dec 01, 2016 | Dec 20, 2016 | $0.34 | 3.72% |
| Aug 18, 2016 | Sep 08, 2016 | $0.34 | 2.56% |
| May 20, 2016 | Jun 07, 2016 | $0.34 | 2.62% |
| Feb 25, 2016 | Mar 14, 2016 | $0.34 | 2.36% |
| Nov 13, 2015 | Dec 03, 2015 | $0.34 | 2.34% |
| Aug 18, 2015 | Sep 03, 2015 | $0.34 | 1.94% |
| May 15, 2015 | Jun 04, 2015 | $0.34 | 2.25% |
| Feb 17, 2015 | Mar 03, 2015 | $0.34 | 2.39% |
| Nov 13, 2014 | Dec 02, 2014 | $0.32 | 2.39% |
| Aug 19, 2014 | Sep 04, 2014 | $0.35 | 2.60% |
| May 16, 2014 | Jun 02, 2014 | $0.35 | 2.69% |
| Feb 20, 2014 | Mar 10, 2014 | $0.35 | 2.72% |
| Nov 18, 2013 | Dec 03, 2013 | $0.33 | 3.35% |
| Aug 16, 2013 | Sep 03, 2013 | $0.32 | 3.02% |
| May 16, 2013 | Jun 03, 2013 | $0.32 | 2.84% |
| Feb 19, 2013 | Mar 07, 2013 | $0.31 | 2.81% |
Key Takeaways
Revenue grew 2.10% annually over 5 years — modest growth
ROE of 21.23% indicates high profitability
Debt/Equity of 2.20 — high leverage
Generating 1.15B in free cash flow
Cash machine — converts 81.42% of earnings into free cash flow
Capital efficient — spends only 2.90% of revenue on capex
Growth
Revenue Growth (5Y)
2.10%
Revenue (1Y)4.31%
Earnings (1Y)N/A
FCF Growth (3Y)16.77%
Quality
Return on Equity
21.23%
ROIC6.40%
Net Margin8.17%
Op. Margin12.50%
Safety
Debt / Equity
2.20
Current Ratio1.04
Interest Coverage2.35
Valuation
P/E Ratio
24.33
Forward P/E10.89
P/B Ratio4.34
EV/EBITDA22.32
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.31% | Revenue Growth (3Y) | 4.36% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2.10% | Earnings Growth (5Y) | 35.60% |
| Profitability | |||
| Revenue (TTM) | 17.26B | Net Income (TTM) | 1.41B |
| ROE | 21.23% | ROA | 3.46% |
| Gross Margin | 51.79% | Operating Margin | 12.50% |
| Net Margin | 8.17% | Free Cash Flow (TTM) | 1.15B |
| ROIC | 6.40% | FCF Growth (3Y) | 16.77% |
| Safety | |||
| Debt / Equity | 2.20 | Current Ratio | 1.04 |
| Interest Coverage | 2.35 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 24.33 | Forward P/E | 10.89 |
| P/B Ratio | 4.34 | P/S Ratio | 1.99 |
| PEG Ratio | -0.14 | Forward PEG | N/A |
| EV/EBITDA | 22.32 | Fwd EV/EBITDA | 18.91 |
| Forward P/S | 2.06 | Fwd Earnings Yield | 9.18% |
| FCF Yield | 3.35% | ||
| Market Cap | 34.31B | Enterprise Value | 48.14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.26B | 16.54B | 15.85B | 14.93B | 15.88B |
| Net Income | 1.41B | -1.64B | -559.00M | -2.45B | 417.00M |
| EPS (Diluted) | 1.20 | -1.45 | -0.50 | -2.20 | 0.38 |
| Gross Profit | 8.94B | 8.06B | 7.65B | 6.97B | 7.59B |
| Operating Income | 2.16B | -303.00M | 433.00M | -2.20B | 1.72B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40.75B | 39.33B | 43.48B | 44.01B | 47.67B |
| Total Liabilities | 32.83B | 33.61B | 35.35B | 35.41B | 36.42B |
| Shareholders' Equity | 7.91B | 5.37B | 7.51B | 7.80B | 10.28B |
| Total Debt | 17.38B | 18.08B | 20.15B | 21.56B | 23.46B |
| Cash & Equivalents | 3.56B | 3.30B | 3.23B | 2.80B | 2.17B |
| Current Assets | 13.95B | 12.55B | 12.49B | 12.05B | 12.57B |
| Current Liabilities | 13.46B | 12.80B | 12.25B | 11.47B | 11.03B |